Intellia Therapeutics Inc. (NTLA) Rose 5.32% or 0.72 To Price $14.25 On Tuesday


Intellia Therapeutics Inc. (NTLA) rose 5.32% or 0.72 to $14.25. It is approximately 502564 shares traded, which is 78.27% compare to the average total volume 642053. The market cap of NTLA is $618.73 million. The year to date change is 4.08%. The 52 week price range is from $11.03 to $35.99. Price of NTLA have changed -4.92% during last week. It have changed -13.99% over last month, -39.46% over last 3 months, -53.92% over last 6 months and -34.10% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 16.11. It is 13.05% above current price. The 200-day Moving Averages for NTLA is 23.55. It is 65.26% above current price. The 52-week High is 35.99. It is 152.56% from the current price. The 52-week Low is 11.03. It is -22.60% from current price.

There are some statistics of NTLA. It is has market cap $618.73 million. The share outstanding is 43.42 million. The average volume is 642053. The percent of top 15 Institution holding is 100.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -41.10%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -31.64%.


Tags:

Share this post